longbridgelongbridge
  • Platform Features
    Features
    Investment ProductsPrivate Wealth ManagementTrading ToolsMarket Data ServicesAnalysis ToolsNews ServicesFor Developers
    Account Types
    For IndividualsFor Institutions
  • Café
longbridge
© 2026 Longbridge|Terms of ServicePrivacy Policy

IPFXU

IPFXU
----

LongbridgeAI

US Weekly Recap: Aerospace and healthcare issuers drive late-March filing activity

RenaissanceCapital
Mar 27, 2026 at 10:24 PM
LongbridgeAII'm LongbridgeAI, I can summarize articles.

The week of March 23rd, 2026, saw significant filing activity in the aerospace and healthcare sectors, despite no traditional IPOs. Three blank check companies, including Inflection Point Acquisition VI, raised a total of $220 million targeting technology-enabled businesses. Other notable filings included Alamar Biosciences and Kailera Therapeutics, each raising $100 million in the healthcare sector. Additionally, several SPACs, such as Collective Acquisition II and Oceanhawk Acquisition, also entered the pipeline with substantial funding plans.

While there were no traditional IPOs this past week, three blank check companies priced, and several sizable deals joined the pipeline.

The week’s three blank check IPOs were led by Inflection Point Acquisition VI (IPFXU), which raised $220 million to target technology-enabled businesses.

Three SPACs also submitted initial filings. Collective Acquisition II (CAIIU) plans to raise $220 million, targeting finance, defense technology, and AI. Oceanhawk Acquisition (OHACU) plans to raise $200 million, backed by investment firm OceanHawk. Research Alliance III (RACC) plans to raise $50 million, formed by RA Capital.

9 Filings During the Week of March 23rd, 2026
Issuer
Business
Deal
Size
SectorLead
Underwriter
Alamar Biosciences (ALMR)$100MHealth CareJP Morgan
Provides a protein biomarker detection platform for disease detection research.
Collective Acquisition II (CAIIU)$220MSPACClear Street
Blank check company targeting finance, defense technology, and AI.
Kailera Therapeutics (KLRA)$100MHealth CareJP Morgan
Phase 3 biotech developing injectable and oral GLP-1s for obesity.
Yesway (YSWY)$300MConsumer StaplesMorgan Stanley
Convenience store chain with over 400 locations throughout seven states.
AsiaPac AdTechinno Group (APAT)$25MTechnologyMaxim
Hong Kong-based adtech platform provider.
Arxis (ARXS)$400MIndustrialsGoldman
Aerospace and defense electronics and components manufacturer.
Research Alliance III (RACC)$50MSPACLeerink Partners
Blank check company formed by RA Capital targeting drug development and healthtech.
Aevex (AVEX)$200MIndustrialsGoldman
Provides military unmanned aircraft systems and services.
Oceanhawk Acquisition (OHACU)$200MSPACBenchmark
Blank check company backed by investment firm OceanHawk.

Login to unlock1,209characters for free

Due to copyright restrictions, please log in to your Longbridge account to view this content.
Thank you for your understanding and support of licensed content.

Related Stocks

Inflection Point Acquisition VI - Unit

Inflection Point Acquisition VI - Unit

USIPFXU

+0.38%

ALTAMIRA THERAPEUTICS LTD

ALTAMIRA THERAPEUTICS LTD

USCYTOF

-29.34%

Aligos Therapeutics

Aligos Therapeutics

USALGS